Question 1

What is Actinium Pharmaceuticals, Inc.?

Accepted Answer

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs not addressed by traditional cancer therapies.

Question 2

What is the focus of Actinium's current clinical pipeline?

Accepted Answer

Actinium's current clinical pipeline is led by ARCs (Antibody Radiation-Conjugates) that are being applied to targeted conditioning, which is intended to selectively deplete a patient's disease or cancer cells and certain immune cells prior to a BMT (bone marrow transplant), gene therapy or adoptive cell therapy (ACT) such as CAR-T to enable engraftment of these transplanted cells with minimal toxicity.

Question 3

What is the purpose of the targeted conditioning approach?

Accepted Answer

The targeted conditioning approach is intended to selectively deplete a patient's disease or cancer cells and certain immune cells prior to a BMT, gene therapy or adoptive cell therapy (ACT) such as CAR-T to enable engraftment of these transplanted cells with minimal toxicity.

Question 4

is a powerful alpha-emitting radioisotope that can be conjugated to monoclonal antibodies to target and deliver potent doses of radiation directly to cancer cells.

5. What are some of Actinium's key pipeline candidates?

Accepted Answer

Actinium's lead pipeline candidates include Iomab-B and Actimab-A, which are being developed for targeted conditioning prior to BMT, gene therapy and ACT, as well as Iomab-ACT, which is being developed for targeted conditioning prior to gene therapy and ACT.

Actinium Pharmaceuticals

Company Overview

Company Name

Address

Website

Phone

About Actinium Pharmaceuticals

Frequently Asked Questions about Actinium Pharmaceuticals

What is Actinium Pharmaceuticals, Inc.?

What is the focus of Actinium's current clinical pipeline?

What is the purpose of the targeted conditioning approach?

is a powerful alpha-emitting radioisotope that can be conjugated to monoclonal antibodies to target and deliver potent doses of radiation directly to cancer cells. 5. What are some of Actinium's key pipeline candidates?

Technologies Used

Social Profiles